# FDA Inspection 1247313 - Carter BloodCare - June 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/ad0bb47a-a615-46f9-b6a5-467ff75fe18c
Source feed: FDA_Inspections

> FDA Inspection 1247313 for Carter BloodCare on June 27, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247313
- Company Name: Carter BloodCare
- Inspection Date: 2024-06-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1070324 - 2018-10-26](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/cfd68e9f-72fb-4a68-a7a3-23c55cb4626a)

Company: https://www.keypedia.com/companies/carter-bloodcare/982c8b4f-590b-426e-b64d-f6e63894ddb1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d